211 related articles for article (PubMed ID: 29396996)
21. Interindividual differences in the analgesic response to ketamine in chronic orofacial pain.
Rabben T; Øye I
Eur J Pain; 2001; 5(3):233-40. PubMed ID: 11558979
[TBL] [Abstract][Full Text] [Related]
22. Ketamine as an analgesic: parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration.
Kronenberg RH
J Pain Palliat Care Pharmacother; 2002; 16(3):27-35. PubMed ID: 14640353
[TBL] [Abstract][Full Text] [Related]
23. Low-dose ketamine adjuvant treatment for refractory pain in children, adolescents and young adults with cancer: a pilot study.
Courade M; Bertrand A; Guerrini-Rousseau L; Pagnier A; Levy D; Lervat C; Cojean N; Ribrault A; Dugue S; Thouvenin S; Piguet C; Schmitt C; Marec-Berard P
BMJ Support Palliat Care; 2022 Nov; 12(e5):e656-e663. PubMed ID: 31151954
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics, absolute bioavailability and tolerability of ketamine after intranasal administration to dexmedetomidine sedated dogs.
Vlerick L; Devreese M; Peremans K; Dockx R; Croubels S; Duchateau L; Polis I
PLoS One; 2020; 15(1):e0227762. PubMed ID: 31929589
[TBL] [Abstract][Full Text] [Related]
25. The effects of an intraperitoneal single low dose of ketamine in attenuating the postoperative skin/muscle incision and retraction-induced pain related to the inhibition of N-methyl-D-aspartate receptors in the spinal cord.
Shen Y; Xu L; Liu M; Lei Y; Gu X; Ma Z
Neurosci Lett; 2016 Mar; 616():211-7. PubMed ID: 26808640
[TBL] [Abstract][Full Text] [Related]
26. Analgesic Effects of Intranasal Ketamine in Rat Models of Facial Pain.
Claudino R; Nones C; Araya E; Chichorro J
J Oral Facial Pain Headache; 2018; 32(3):238–346. PubMed ID: 29697717
[TBL] [Abstract][Full Text] [Related]
27. [Low doses ketamine: antihyperalgesic drug, non-analgesic].
Richebé P; Rivat C; Rivalan B; Maurette P; Simonnet G
Ann Fr Anesth Reanim; 2005; 24(11-12):1349-59. PubMed ID: 16115745
[TBL] [Abstract][Full Text] [Related]
28. Emerging concepts on the use of ketamine for chronic pain.
Yang Y; Maher DP; Cohen SP
Expert Rev Clin Pharmacol; 2020 Feb; 13(2):135-146. PubMed ID: 31990596
[No Abstract] [Full Text] [Related]
29. Intranasal ketamine for acute cluster headache attacks-Results from a proof-of-concept open-label trial.
Petersen AS; Pedersen AS; Barloese MCJ; Holm P; Pedersen O; Jensen RH; Snoer AH
Headache; 2022 Jan; 62(1):26-35. PubMed ID: 34806165
[TBL] [Abstract][Full Text] [Related]
30. The improvement of the anti-hyperalgesic effect of ketamine and of its isomers by the administration of ifenprodil.
Rondon ES; Vieira AS; Valadão CA; Parada CA
Eur J Pharmacol; 2010 Nov; 647(1-3):84-9. PubMed ID: 20826141
[TBL] [Abstract][Full Text] [Related]
31. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
[TBL] [Abstract][Full Text] [Related]
32. Chronic administration of ketamine for analgesia.
Ben-Ari A; Lewis MC; Davidson E
J Pain Palliat Care Pharmacother; 2007; 21(1):7-14. PubMed ID: 17430824
[TBL] [Abstract][Full Text] [Related]
33. Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?
Okamoto Y; Tsuneto S; Tanimukai H; Matsuda Y; Ohno Y; Tsugane M; Uejima E
Am J Hosp Palliat Care; 2013 Aug; 30(5):450-4. PubMed ID: 22833552
[TBL] [Abstract][Full Text] [Related]
34. Repeated and escalating preoperative subanesthetic doses of ketamine for postoperative pain control in patients undergoing tumor resection: a randomized, placebo-controlled, double-blind trial.
Rakhman E; Shmain D; White I; Ekstein MP; Kollender Y; Chazan S; Dadia S; Bickels J; Amar E; Weinbroum AA
Clin Ther; 2011 Jul; 33(7):863-73. PubMed ID: 21722959
[TBL] [Abstract][Full Text] [Related]
35. Case Report: Utility of Ketamine, Lidocaine, and Mexiletine as Nonopioid Adjuvants in Complex Cancer-Associated Pain.
Hakim RC; Edmonds KP; Atayee RS
J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):15-19. PubMed ID: 29737933
[TBL] [Abstract][Full Text] [Related]
36. The early and delayed analgesic effects of ketamine after total hip arthroplasty: a prospective, randomized, controlled, double-blind study.
Remérand F; Le Tendre C; Baud A; Couvret C; Pourrat X; Favard L; Laffon M; Fusciardi J
Anesth Analg; 2009 Dec; 109(6):1963-71. PubMed ID: 19923527
[TBL] [Abstract][Full Text] [Related]
37. Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease.
Neri CM; Pestieau SR; Darbari DS
Paediatr Anaesth; 2013 Aug; 23(8):684-9. PubMed ID: 23565738
[TBL] [Abstract][Full Text] [Related]
38. Ketamine in cancer pain: an update.
Mercadante S
Palliat Med; 1996 Jul; 10(3):225-30. PubMed ID: 8817593
[TBL] [Abstract][Full Text] [Related]
39. Intranasal sufentanil/midazolam versus ketamine/midazolam for analgesia/sedation in the pediatric population prior to undergoing multiple dental extractions under general anesthesia: a prospective, double-blind, randomized comparison.
Roelofse JA; Shipton EA; de la Harpe CJ; Blignaut RJ
Anesth Prog; 2004; 51(4):114-21. PubMed ID: 15675259
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
